Artiva Biotherapeutics, Inc. (ARTV) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$76.75M | -39.5% |
| 2024 | -$55.03M | -16.0% |
| 2023 | -$47.43M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$76.75M | -39.5% |
| 2024 | -$55.03M | -16.0% |
| 2023 | -$47.43M | — |